Clinical Trial Update: Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients [NA]

View source ↗

Summary

A clinical trial is evaluating whether probiotic supplementation can prevent neratinib-induced diarrhea in patients with HER2-positive breast cancer. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Probiotics
• neratinib (neratinib)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: HER2-positive Breast Cancer, Diarrhea Caused by Drug | NA | Status: RECRUITING